Go to our new-look site, it combines the Biotechnology and Science Learning Hubs with a new look and new functionality. This is our legacy site and is no longer maintained.

Skip to page content

Site navigation


Living Cell Technologies

Living Cell Technologies (LCT) has developed technologies for transplanting healthy cells into people to replace or repair damaged organs.

They are using this technology to develop treatments for type I diabetes, Huntington’s disease, stroke, hearing loss and haemophilia.

LCT uses pig cells that are coated in a protective gel made from an extract of seaweed. The protective coating prevents the animal cells from being attacked by the patient’s immune system. Therefore, patients receiving treatment with these cells do not need to take toxic, immunosuppressive drugs.

Recent projects
In 2007, LCT started a human clinical trial using pig cells to treat people with type I diabetes.

Living Cell Technologies
Web Address:
www.lctglobal.com
Type:
Company
Contact:
PO Box 23 566
Hunters Corner
Papatoetoe
Auckland
New Zealand

Phone: +64 9 276 2690
Fax: +64 9 276 2691
Email: lct@lctglobal.com
Activities:
Research, development, commercialisation and marketing.

Metadata

Return to top